id stringlengths 11 11 | tags stringlengths 10 777 | text stringlengths 2 1.5k | dataset_num int64 1 3 | tokens list | ner_tags list |
|---|---|---|---|---|---|
NCT02665338 | 1:14:chronic_disease | Schizophrenia | 2 | [
"Schizophrenia"
] | [
2
] |
NCT02441062 | 1:45:treatment,,78:81:treatment,82:89:treatment | Peptide receptor radionuclide therapy (PRRT) within 4 weeks of Ga-68 DOTATOC PET/CT scan | 2 | [
"Peptide",
"receptor",
"radionuclide",
"therapy",
"(",
"PRRT",
")",
"within",
"4",
"weeks",
"of",
"Ga-68",
"DOTATOC",
"PET/CT",
"scan"
] | [
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02422641 | 1:16:cancer,18:29:cancer,31:42:cancer,48:61:cancer | TRIPLE NEGATIVE (ER-negative, PR-negative, and HER2-negative disease) | 2 | [
"TRIPLE",
"NEGATIVE",
"(",
"ER-negative",
",",
"PR-negative",
",",
"and",
"HER2-negative",
"disease",
")"
] | [
3,
3,
0,
3,
0,
3,
0,
0,
3,
0,
0
] |
NCT01766297 | 1:24:treatment | Prior radiation therapy to the ipsilateral breast or thorax | 2 | [
"Prior",
"radiation",
"therapy",
"to",
"the",
"ipsilateral",
"breast",
"or",
"thorax"
] | [
1,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT01515527 | 14:34:chronic_disease | Uncontrolled intercurrent illness | 2 | [
"Uncontrolled",
"intercurrent",
"illness"
] | [
0,
2,
2
] |
NCT02064296 | 1:29:chronic_disease,39:52:chronic_disease,60:70:chronic_disease,76:93:chronic_disease, | Severe psychiatric illnesses (current schizophrenia, major depression with suicidal ideation, substance abuse within two years) | 2 | [
"Severe",
"psychiatric",
"illnesses",
"(",
"current",
"schizophrenia",
",",
"major",
"depression",
"with",
"suicidal",
"ideation",
",",
"substance",
"abuse",
"within",
"two",
"years",
")"
] | [
2,
2,
2,
0,
0,
2,
0,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT03062111 | 1:19:chronic_disease | Neurogenic bladder | 2 | [
"Neurogenic",
"bladder"
] | [
2,
2
] |
NCT01799538 | 1:14:treatment | tissue biopsy | 2 | [
"tissue",
"biopsy"
] | [
1,
1
] |
NCT01220583 | 1:16:chronic_disease,20:36:chronic_disease,47:70:treatment | Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration | 2 | [
"Acute",
"bacterial",
"or",
"fungal",
"infection",
"requiring",
"intravenous",
"antibiotics",
"at",
"the",
"time",
"of",
"registration"
] | [
2,
2,
0,
2,
2,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT01668082 | 1:31:treatment,48:59:cancer,54:59:cancer,63:84:treatment,104:110:treatment, | Pre-operative brain MR imaging suggestive of a brain tumor or pre-operative imaging showing a tumor or biopsy of a tumor mass prior to planned resection of the mass | 2 | [
"Pre-operative",
"brain",
"MR",
"imaging",
"suggestive",
"of",
"a",
"brain",
"tumor",
"or",
"pre-operative",
"imaging",
"showing",
"a",
"tumor",
"or",
"biopsy",
"of",
"a",
"tumor",
"mass",
"prior",
"to",
"planned",
"resection",
"of",
"the",
"mass"
] | [
1,
3,
3,
1,
0,
0,
0,
0,
3,
0,
1,
1,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02199236 | 24:43:treatment | Patients on concurrent anti-cancer therapy other than that allowed in the study | 2 | [
"Patients",
"on",
"concurrent",
"anti-cancer",
"therapy",
"other",
"than",
"that",
"allowed",
"in",
"the",
"study"
] | [
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT01670877 | 24:39:chronic_disease,41:61:chronic_disease,79:90:chronic_disease | History of significant cardiac disease, cardiac risk factors, or uncontrolled arrhythmias | 2 | [
"History",
"of",
"significant",
"cardiac",
"disease",
",",
"cardiac",
"risk",
"factors",
",",
"or",
"uncontrolled",
"arrhythmias"
] | [
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
2
] |
NCT03017937 | 11:27:chronic_disease | Any known seizure disorder | 2 | [
"Any",
"known",
"seizure",
"disorder"
] | [
0,
0,
2,
2
] |
NCT02398773 | 127:134:allergy_name | Patient must NOT have a history of allergic reaction attributable to compounds of similar chemical or biologic composition to 18F-FES | 2 | [
"Patient",
"must",
"NOT",
"have",
"a",
"history",
"of",
"allergic",
"reaction",
"attributable",
"to",
"compounds",
"of",
"similar",
"chemical",
"or",
"biologic",
"composition",
"to",
"18F-FES"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
4
] |
NCT02301260 | 24:49:chronic_disease | a current diagnosis of Major Depressive Disorder | 2 | [
"a",
"current",
"diagnosis",
"of",
"Major",
"Depressive",
"Disorder"
] | [
0,
0,
0,
0,
2,
2,
2
] |
NCT02073292 | 1:28:chronic_disease | Systemic or local infection | 2 | [
"Systemic",
"or",
"local",
"infection"
] | [
2,
2,
2,
2
] |
NCT01568918 | 17:34:chronic_disease | Patients with a mental disability | 2 | [
"Patients",
"with",
"a",
"mental",
"disability"
] | [
0,
0,
0,
2,
2
] |
NCT02474368 | 1:39:treatment | Granulocyte stimulating factor (G-CSF) | 2 | [
"Granulocyte",
"stimulating",
"factor",
"(",
"G-CSF",
")"
] | [
1,
1,
1,
1,
0,
0
] |
NCT02778867 | 32:36:allergy_name | Have history of anaphylaxis to milk | 2 | [
"Have",
"history",
"of",
"anaphylaxis",
"to",
"milk"
] | [
0,
0,
0,
0,
0,
4
] |
NCT02047721 | 1:12:treatment,, | medications affecting weight, Energy Intake (EI) or Energy Expenditure (EE) in the last 6 months | 2 | [
"medications",
"affecting",
"weight",
",",
"Energy",
"Intake",
"(",
"EI",
")",
"or",
"Energy",
"Expenditure",
"(",
"EE",
")",
"in",
"the",
"last",
"6",
"months"
] | [
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02181478 | 1:32:cancer,34:56:cancer,58:80:cancer,190:196:treatment | Myelodysplastic syndromes (MDS), Intermediate-1 (INT-1), intermediate-2 (INT-2) or high Revised International Prognostic Scoring System (IPSS-R) score that has failed at least 1 first line therap | 2 | [
"Myelodysplastic",
"syndromes",
"(",
"MDS",
")",
",",
"Intermediate-1",
"(",
"INT-1",
")",
",",
"intermediate-2",
"(",
"INT-2",
")",
"or",
"high",
"Revised",
"International",
"Prognostic",
"Scoring",
"System",
"(",
"IPSS-R",
")",
"score",
"that",
"has",
"faile... | [
3,
3,
3,
0,
0,
0,
3,
3,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01962415 | 1:19:chronic_disease | alpha mannosidosis | 2 | [
"alpha",
"mannosidosis"
] | [
2,
2
] |
NCT02582827 | 24:51:chronic_disease,83:104:treatment,108:123:treatment,136:143:treatment | History of symptomatic peripheral vascular disease (venous or arterial) requiring surgical intervention or chronic therapy (other than aspirin) | 2 | [
"History",
"of",
"symptomatic",
"peripheral",
"vascular",
"disease",
"(",
"venous",
"or",
"arterial",
")",
"requiring",
"surgical",
"intervention",
"or",
"chronic",
"therapy",
"(",
"other",
"than",
"aspirin",
")"
] | [
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
0,
0,
0,
1,
0
] |
NCT02819440 | 7:20:chronic_disease | Known HIV infection | 2 | [
"Known",
"HIV",
"infection"
] | [
0,
2,
2
] |
NCT02215096 | 1:21:cancer,16:21:cancer,65:71:treatment | PTEN deficient tumor as documented from archival or fresh (from biopsy) tumor tissue analyzed by GlaxoSmithKline selected laboratory | 2 | [
"PTEN",
"deficient",
"tumor",
"as",
"documented",
"from",
"archival",
"or",
"fresh",
"(",
"from",
"biopsy",
")",
"tumor",
"tissue",
"analyzed",
"by",
"GlaxoSmithKline",
"selected",
"laboratory"
] | [
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02525861 | 12:46:treatment,, | Documented Alpha1-Proteinase Inhibitor (A1PI) genotype of Pi*Z/Z, Pi*Z/Null, Pi*Malton/Z, Pi*Null/Null, or other at-risk allelic combinations such as SZ (excluding MS and MZ) and an endogenous A1PI plasma levels of ≤11 μM | 2 | [
"Documented",
"Alpha1-Proteinase",
"Inhibitor",
"(",
"A1PI",
")",
"genotype",
"of",
"Pi",
"*",
"Z/Z",
",",
"Pi",
"*",
"Z/Null",
",",
"Pi",
"*",
"Malton/Z",
",",
"Pi",
"*",
"Null/Null",
",",
"or",
"other",
"at-risk",
"allelic",
"combinations",
"such",
"as",... | [
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02513797 | 23:38:chronic_disease, | Documented history of unstable angina within 3 months prior to the planned study intervention | 2 | [
"Documented",
"history",
"of",
"unstable",
"angina",
"within",
"3",
"months",
"prior",
"to",
"the",
"planned",
"study",
"intervention"
] | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01772329 | 42:58:chronic_disease,, | any co-morbidity which results in severe systemic disease limiting function {as defined by the American Society of Anesthesiology (ASA) physical status classification > 3} | 2 | [
"any",
"co-morbidity",
"which",
"results",
"in",
"severe",
"systemic",
"disease",
"limiting",
"function",
"{",
"as",
"defined",
"by",
"the",
"American",
"Society",
"of",
"Anesthesiology",
"(",
"ASA",
")",
"physical",
"status",
"classification",
">",
"3",
"}"
] | [
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02494869 | 14:20:chronic_disease | Uncontrolled asthma | 2 | [
"Uncontrolled",
"asthma"
] | [
0,
2
] |
NCT00285935 | 25:46:chronic_disease,, | No MRI exclusions (e.g. severe claustrophobia, metal implants, pacemakers, BMI >38) | 2 | [
"No",
"MRI",
"exclusions",
"(",
"e.g",
".",
"severe",
"claustrophobia",
",",
"metal",
"implants",
",",
"pacemakers",
",",
"BMI",
">",
"38",
")"
] | [
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03041844 | 8:30:chronic_disease,,,, | Severe vascular insufficiency (ankle-brachial index lower than 0.75 or toe-brachial index below 0.5) | 2 | [
"Severe",
"vascular",
"insufficiency",
"(",
"ankle-brachial",
"index",
"lower",
"than",
"0.75",
"or",
"toe-brachial",
"index",
"below",
"0.5",
")"
] | [
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02803359 | 12:21:allergy_name | Allergy to Lidocaine | 2 | [
"Allergy",
"to",
"Lidocaine"
] | [
0,
0,
4
] |
NCT02743728 | 1:20:chronic_disease | Metabolic Disorders | 2 | [
"Metabolic",
"Disorders"
] | [
2,
2
] |
NCT02816736 | 22:47:treatment | patients who require chronic inotropic therapy | 2 | [
"patients",
"who",
"require",
"chronic",
"inotropic",
"therapy"
] | [
0,
0,
0,
1,
1,
1
] |
NCT02512718 | 14:28:chronic_disease,, | pathological hyperlipidemia (2 consecutive fasting triglyceride levels > 500 mg/dL) | 2 | [
"pathological",
"hyperlipidemia",
"(",
"2",
"consecutive",
"fasting",
"triglyceride",
"levels",
">",
"500",
"mg/dL",
")"
] | [
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03183102 | 12:40:chronic_disease | History of venous thromboembolic events | 2 | [
"History",
"of",
"venous",
"thromboembolic",
"events"
] | [
0,
0,
2,
2,
2
] |
NCT02828618 | 22:32:chronic_disease,, | Neurologic function: Neuropathy (sensory and motor) less than or equal to CTCAE Grade 1 | 2 | [
"Neurologic",
"function",
":",
"Neuropathy",
"(",
"sensory",
"and",
"motor",
")",
"less",
"than",
"or",
"equal",
"to",
"CTCAE",
"Grade",
"1"
] | [
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02278198 | 17:31:cancer | nown metastatic thyroid cancer | 2 | [
"nown",
"metastatic",
"thyroid",
"cancer"
] | [
0,
0,
3,
3
] |
NCT01539109 | 1:16:treatment,18:24:treatment,29:45:treatment | Implanted pumps, shunts, or neurostimulators | 2 | [
"Implanted",
"pumps",
",",
"shunts",
",",
"or",
"neurostimulators"
] | [
1,
1,
0,
1,
0,
0,
1
] |
NCT01351103 | 1:7:cancer | tumors of any histological origin with documented genetic alterations upstream in the Wnt signaling pathway are eligible with prior agreement with Novartis | 2 | [
"tumors",
"of",
"any",
"histological",
"origin",
"with",
"documented",
"genetic",
"alterations",
"upstream",
"in",
"the",
"Wnt",
"signaling",
"pathway",
"are",
"eligible",
"with",
"prior",
"agreement",
"with",
"Novartis"
] | [
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03060473 | 13:26:chronic_disease,, | Significant renal disease defined as serum creatinine known to be >2.0 mg/dl | 2 | [
"Significant",
"renal",
"disease",
"defined",
"as",
"serum",
"creatinine",
"known",
"to",
"be",
">",
"2.0",
"mg/dl"
] | [
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02057133 | 156:217:treatment | Have serious preexisting medical conditions that, in the judgment of the investigator, would preclude participation in this study (for example, history of major surgical resection involving the stomach or small bowel) | 2 | [
"Have",
"serious",
"preexisting",
"medical",
"conditions",
"that",
",",
"in",
"the",
"judgment",
"of",
"the",
"investigator",
",",
"would",
"preclude",
"participation",
"in",
"this",
"study",
"(",
"for",
"example",
",",
"history",
"of",
"major",
"surgical",
"r... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
0
] |
NCT02512718 | 14:28:chronic_disease,, | Pathological hyperlipidemia (2 consecutive fasting triglyceride levels > 500 mg/dL) | 2 | [
"Pathological",
"hyperlipidemia",
"(",
"2",
"consecutive",
"fasting",
"triglyceride",
"levels",
">",
"500",
"mg/dL",
")"
] | [
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02015390 | 28:45:allergy_name | Known allergic reaction to titanium implants | 2 | [
"Known",
"allergic",
"reaction",
"to",
"titanium",
"implants"
] | [
0,
0,
0,
0,
4,
4
] |
NCT02418195 | 1:17:chronic_disease | Anorexia nervosa | 2 | [
"Anorexia",
"nervosa"
] | [
2,
2
] |
NCT00291525 | 1:28:chronic_disease | Chronic atrial fibrillation | 2 | [
"Chronic",
"atrial",
"fibrillation"
] | [
2,
2,
2
] |
NCT03157713 | 1:7:chronic_disease, | stroke in the past 6 mo | 2 | [
"stroke",
"in",
"the",
"past",
"6",
"mo"
] | [
2,
0,
0,
0,
0,
0
] |
NCT03076021 | 1:8:chronic_disease,, | Obesity, BMI ≥ 30 kg/m2 | 2 | [
"Obesity",
",",
"BMI",
"≥",
"30",
"kg/m2"
] | [
2,
0,
0,
0,
0,
0
] |
NCT02719327 | 27:31:allergy_name | Known hypersensitivity to fish | 2 | [
"Known",
"hypersensitivity",
"to",
"fish"
] | [
0,
0,
0,
4
] |
NCT02011971 | 1:22:chronic_disease,30:38:chronic_disease,40:48:chronic_disease,50:63:chronic_disease,65:78:cancer,80:90:chronic_disease | Major medical disease (e.g., epilepsy, diabetes, heart disease, active cancer, depression) | 2 | [
"Major",
"medical",
"disease",
"(",
"e.g.",
",",
"epilepsy",
",",
"diabetes",
",",
"heart",
"disease",
",",
"active",
"cancer",
",",
"depression",
")"
] | [
2,
2,
2,
0,
0,
0,
2,
0,
2,
0,
2,
2,
0,
3,
3,
0,
2,
0
] |
NCT02366819 | 1:25:cancer | gross peritoneal disease | 2 | [
"gross",
"peritoneal",
"disease"
] | [
3,
3,
3
] |
NCT02819141 | 1:19:treatment, | General anesthesia within 12 hours prior to enrollment | 2 | [
"General",
"anesthesia",
"within",
"12",
"hours",
"prior",
"to",
"enrollment"
] | [
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02210078 | 15:32:chronic_disease,, | Patients with active acute GVHD grades II-IV | 2 | [
"Patients",
"with",
"active",
"acute",
"GVHD",
"grades",
"II-IV"
] | [
0,
0,
2,
2,
2,
0,
0
] |
NCT02278315 | 43:59:cancer | Histologically or cytologically confirmed multiple myeloma | 2 | [
"Histologically",
"or",
"cytologically",
"confirmed",
"multiple",
"myeloma"
] | [
0,
0,
0,
0,
3,
3
] |
NCT03170453 | 1:31:chronic_disease | disruptive or violent behavior | 2 | [
"disruptive",
"or",
"violent",
"behavior"
] | [
2,
2,
2,
2
] |
NCT02021604 | ,96:121:treatment | Nursing mothers who are unwilling to discontinue breastfeeding their infant for 48 hours after Fluorodopa F 18 injection | 2 | [
"Nursing",
"mothers",
"who",
"are",
"unwilling",
"to",
"discontinue",
"breastfeeding",
"their",
"infant",
"for",
"48",
"hours",
"after",
"Fluorodopa",
"F",
"18",
"injection"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1
] |
NCT02826343 | 1:17:treatment | Liver transplant | 2 | [
"Liver",
"transplant"
] | [
1,
1
] |
NCT02516241 | 28:38:chronic_disease,42:64:chronic_disease,130:138:chronic_disease,142:150:chronic_disease,167:181:chronic_disease,197:215:chronic_disease,227:246:treatment,298:314:treatment,,446:460:chronic_disease | Active or prior documented autoimmune or inflammatory disorders. The following are exceptions to this criterion: • Patients with vitiligo or alopecia • Patients with hypothyroidism (eg, following Hashimoto syndrome) stable on hormone replacement • Any chronic skin condition that does not require systemic therapy • Pati... | 2 | [
"Active",
"or",
"prior",
"documented",
"autoimmune",
"or",
"inflammatory",
"disorders",
".",
"The",
"following",
"are",
"exceptions",
"to",
"this",
"criterion",
":",
"•",
"Patients",
"with",
"vitiligo",
"or",
"alopecia",
"•",
"Patients",
"with",
"hypothyroidism",
... | [
0,
0,
0,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
0,
0,
0,
2,
0,
0,
0,
0,
2,
2,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0... |
NCT01849146 | ,16:44:treatment | 3 weeks from a non-nitrosourea chemotherapy | 2 | [
"3",
"weeks",
"from",
"a",
"non-nitrosourea",
"chemotherapy"
] | [
0,
0,
0,
0,
1,
1
] |
NCT02433158 | 15:29:treatment | Completion of Study B5201002 | 2 | [
"Completion",
"of",
"Study",
"B5201002"
] | [
0,
0,
1,
1
] |
NCT02606045 | 45:49:chronic_disease | Willingness to comply with randomization to rVWF or TA study arms | 2 | [
"Willingness",
"to",
"comply",
"with",
"randomization",
"to",
"rVWF",
"or",
"TA",
"study",
"arms"
] | [
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0
] |
NCT03043742 | ,,50:65:chronic_disease | Increased Troponin T (> 3X ULN) in patients with unstable angina at time of intervention | 2 | [
"Increased",
"Troponin",
"T",
"(",
">",
"3X",
"ULN",
")",
"in",
"patients",
"with",
"unstable",
"angina",
"at",
"time",
"of",
"intervention"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0
] |
NCT02564978 | 12:33:treatment | History of vitreoretinal surgery | 2 | [
"History",
"of",
"vitreoretinal",
"surgery"
] | [
0,
0,
1,
1
] |
NCT02922881 | 1:18:treatment,8:18:treatment,20:23:treatment,24:28:treatment, | Stable medication (IMM/5ASA) use or no medication use for the past 6 weeks | 2 | [
"Stable",
"medication",
"(",
"IMM/5ASA",
")",
"use",
"or",
"no",
"medication",
"use",
"for",
"the",
"past",
"6",
"weeks"
] | [
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02998021 | 1:16:chronic_disease | upper limb pain that interferes with the ability to propel or transfer | 2 | [
"upper",
"limb",
"pain",
"that",
"interferes",
"with",
"the",
"ability",
"to",
"propel",
"or",
"transfer"
] | [
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02832115 | 7:17:treatment | known LIMA graft | 2 | [
"known",
"LIMA",
"graft"
] | [
0,
1,
1
] |
NCT03151434 | 83:91:allergy_name,93:104:allergy_name,106:117:allergy_name | Known allergy or other contraindications to the study medications , which include dilaudid, bupivacaine, ropivacaine | 2 | [
"Known",
"allergy",
"or",
"other",
"contraindications",
"to",
"the",
"study",
"medications",
",",
"which",
"include",
"dilaudid",
",",
"bupivacaine",
",",
"ropivacaine"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
4,
0,
4,
0,
4
] |
NCT02924194 | 1:9:chronic_disease | Dementia per DSM-V criteria | 2 | [
"Dementia",
"per",
"DSM-V",
"criteria"
] | [
2,
0,
0,
0
] |
NCT01570998 | 1:11:cancer | High grade | 2 | [
"High",
"grade"
] | [
3,
3
] |
NCT02139436 | ,28:43:chronic_disease | current grade 2 or greater pressure ulcers at relevant contact sites | 2 | [
"current",
"grade",
"2",
"or",
"greater",
"pressure",
"ulcers",
"at",
"relevant",
"contact",
"sites"
] | [
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0
] |
NCT01842399 | 28:41:treatment,43:50:treatment,54:60:treatment,110:123:treatment | Taking supplements such as Ginkgo biloba, Ginseng or Ginger due to their increased risk of bleeding with the muscle biopsy | 2 | [
"Taking",
"supplements",
"such",
"as",
"Ginkgo",
"biloba",
",",
"Ginseng",
"or",
"Ginger",
"due",
"to",
"their",
"increased",
"risk",
"of",
"bleeding",
"with",
"the",
"muscle",
"biopsy"
] | [
0,
0,
0,
0,
1,
1,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01600040 | 1:32:cancer | uterine papillary serous cancer | 2 | [
"uterine",
"papillary",
"serous",
"cancer"
] | [
3,
3,
3,
3
] |
NCT02040610 | 13:31:cancer | Evidence of distant metastases | 2 | [
"Evidence",
"of",
"distant",
"metastases"
] | [
0,
0,
3,
3
] |
NCT02273362 | ,,,,112:123:treatment | Willingness to use adequate contraception to avoid pregnancy or impregnation until 2 weeks after discontinuing study agent | 2 | [
"Willingness",
"to",
"use",
"adequate",
"contraception",
"to",
"avoid",
"pregnancy",
"or",
"impregnation",
"until",
"2",
"weeks",
"after",
"discontinuing",
"study",
"agent"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01954576 | 166:176:cancer | Because the genetic analyses described in Section 8.0 will be performed under HRPO# 201111001 (Analysis of Histological, Genomic, Molecular, and Clinical Factors in CNS Cancer: the Neuro-Oncology Group), for patients enrolling in this trial at WUSM, it is required that WUSM patients must also enroll in HRPO# 201111001.... | 2 | [
"Because",
"the",
"genetic",
"analyses",
"described",
"in",
"Section",
"8.0",
"will",
"be",
"performed",
"under",
"HRPO",
"#",
"201111001",
"(",
"Analysis",
"of",
"Histological",
",",
"Genomic",
",",
"Molecular",
",",
"and",
"Clinical",
"Factors",
"in",
"CNS",... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0... |
NCT02315950 | 1:15:chronic_disease | Claustrophobic | 2 | [
"Claustrophobic"
] | [
2
] |
NCT02549833 | 1:29:treatment | Prior radiation therapy (RT) after the initial diagnosis will be allowed | 2 | [
"Prior",
"radiation",
"therapy",
"(",
"RT",
")",
"after",
"the",
"initial",
"diagnosis",
"will",
"be",
"allowed"
] | [
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02429830 | 16:27:chronic_disease | Diagnosed with Scleroderma | 2 | [
"Diagnosed",
"with",
"Scleroderma"
] | [
0,
0,
2
] |
NCT03104725 | 1:3:chronic_disease, | PD diagnosed within the past 5 years | 2 | [
"PD",
"diagnosed",
"within",
"the",
"past",
"5",
"years"
] | [
2,
0,
0,
0,
0,
0,
0
] |
NCT01925573 | 4:19:chronic_disease | No active bleeding or pathological condition that carries a high risk of bleeding (e.g., tumor involving major vessels or known varices) | 2 | [
"No",
"active",
"bleeding",
"or",
"pathological",
"condition",
"that",
"carries",
"a",
"high",
"risk",
"of",
"bleeding",
"(",
"e.g.",
",",
"tumor",
"involving",
"major",
"vessels",
"or",
"known",
"varices",
")"
] | [
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02973139 | 1:24:chronic_disease | Hemodynamic instability | 2 | [
"Hemodynamic",
"instability"
] | [
2,
2
] |
NCT02587936 | 8:27:treatment | Use of hypoglycemic agents | 2 | [
"Use",
"of",
"hypoglycemic",
"agents"
] | [
0,
0,
1,
1
] |
NCT02830360 | 22:24:chronic_disease,61:71:treatment,73:80:treatment,93:133:treatment, | One of the following VT events while not being treated with amiodarone, sotalol, or another class I or class III antiarrhythmic drug) within the last 6 months | 2 | [
"One",
"of",
"the",
"following",
"VT",
"events",
"while",
"not",
"being",
"treated",
"with",
"amiodarone",
",",
"sotalol",
",",
"or",
"another",
"class",
"I",
"or",
"class",
"III",
"antiarrhythmic",
"drug",
")",
"within",
"the",
"last",
"6",
"months"
] | [
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02456857 | ,34:47:treatment | Received at least one dose of an anthracycline-based NACT | 2 | [
"Received",
"at",
"least",
"one",
"dose",
"of",
"an",
"anthracycline-based",
"NACT"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02237183 | 17:28:chronic_disease,44:56:treatment,60:88:treatment,, | Due to risk for hypotension in patients on vasodilators or antihypertensive medications, participants must not have blood pressure < 95 mm Hg systolic | 2 | [
"Due",
"to",
"risk",
"for",
"hypotension",
"in",
"patients",
"on",
"vasodilators",
"or",
"antihypertensive",
"medications",
",",
"participants",
"must",
"not",
"have",
"blood",
"pressure",
"<",
"95",
"mm",
"Hg",
"systolic"
] | [
0,
0,
0,
0,
2,
0,
0,
0,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02145351 | 38:45:chronic_disease | Other clinically important causes of dyspnea | 2 | [
"Other",
"clinically",
"important",
"causes",
"of",
"dyspnea"
] | [
0,
0,
0,
0,
0,
2
] |
NCT01791543 | 1:23:chronic_disease | Ventricular arrhythmia is recurrent and symptomatic | 2 | [
"Ventricular",
"arrhythmia",
"is",
"recurrent",
"and",
"symptomatic"
] | [
2,
2,
0,
0,
0,
0
] |
NCT02140554 | 18:69:treatment, | Participation in another clinical study with an investigational drug within 30 days of Screening | 2 | [
"Participation",
"in",
"another",
"clinical",
"study",
"with",
"an",
"investigational",
"drug",
"within",
"30",
"days",
"of",
"Screening"
] | [
0,
0,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT03096288 | 11:26:chronic_disease | stable or unstable angina | 2 | [
"stable",
"or",
"unstable",
"angina"
] | [
0,
0,
2,
2
] |
NCT02905578 | 1:52:chronic_disease | Glucose-6-phosphate dehydrogenase (G6PD) deficiency | 2 | [
"Glucose-6-phosphate",
"dehydrogenase",
"(",
"G6PD",
")",
"deficiency"
] | [
2,
2,
2,
2,
0,
0
] |
NCT02004275 | 21:28:cancer,62:75:treatment,77:79:treatment | relapsed disease is myeloma that has previously responded to prior therapy (MR or better) and subsequently progressed | 2 | [
"relapsed",
"disease",
"is",
"myeloma",
"that",
"has",
"previously",
"responded",
"to",
"prior",
"therapy",
"(",
"MR",
"or",
"better",
")",
"and",
"subsequently",
"progressed"
] | [
0,
0,
0,
3,
0,
0,
0,
0,
0,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02852538 | 1:22:chronic_disease | intellectual disorder | 2 | [
"intellectual",
"disorder"
] | [
2,
2
] |
NCT02543944 | 1:25:chronic_disease | wide complex tachycardia | 2 | [
"wide",
"complex",
"tachycardia"
] | [
2,
2,
2
] |
NCT03168776 | 26:70:treatment | Current participation in another investigational drug or device study | 2 | [
"Current",
"participation",
"in",
"another",
"investigational",
"drug",
"or",
"device",
"study"
] | [
0,
0,
0,
1,
1,
1,
1,
1,
1
] |
NCT01905709 | 36:39:chronic_disease | Subject has recurrent or relapsing CDI | 2 | [
"Subject",
"has",
"recurrent",
"or",
"relapsing",
"CDI"
] | [
0,
0,
0,
0,
0,
2
] |
NCT03178552 | 24:38:cancer | Symptomatic, untreated CNS metastases | 2 | [
"Symptomatic",
",",
"untreated",
"CNS",
"metastases"
] | [
0,
0,
0,
3,
3
] |
NCT02315196 | 1:24:chronic_disease,26:38:chronic_disease,40:67:chronic_disease,72:101:chronic_disease, | Nervous system disorder (paresthesias, peripheral motor neuropathy, or peripheral sensory neuropathy) >= grade 2, per the Common Terminology Criteria for Adverse Events version 4.0 (CTCAE v4.0) | 2 | [
"Nervous",
"system",
"disorder",
"(",
"paresthesias",
",",
"peripheral",
"motor",
"neuropathy",
",",
"or",
"peripheral",
"sensory",
"neuropathy",
")",
">",
"=",
"grade",
"2",
",",
"per",
"the",
"Common",
"Terminology",
"Criteria",
"for",
"Adverse",
"Events",
"... | [
2,
2,
2,
0,
2,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02495168 | 41:53:treatment | Twice-a-day controlled-release forms of theophylline: 24 hours | 2 | [
"Twice-a-day",
"controlled-release",
"forms",
"of",
"theophylline",
":",
"24",
"hours"
] | [
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02069899 | 38:45:treatment | Having received at least one dose of NI-0501 | 2 | [
"Having",
"received",
"at",
"least",
"one",
"dose",
"of",
"NI-0501"
] | [
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02565901 | 7:35:cancer | Known parenchymal brain metastasis | 2 | [
"Known",
"parenchymal",
"brain",
"metastasis"
] | [
0,
3,
3,
3
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.